Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BIVALIRUDIN Cause Thrombosis in device? 63 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Thrombosis in device have been filed in association with BIVALIRUDIN (BIVALIRUDIN). This represents 7.5% of all adverse event reports for BIVALIRUDIN.

63
Reports of Thrombosis in device with BIVALIRUDIN
7.5%
of all BIVALIRUDIN reports
9
Deaths
8
Hospitalizations

How Dangerous Is Thrombosis in device From BIVALIRUDIN?

Of the 63 reports, 9 (14.3%) resulted in death, 8 (12.7%) required hospitalization, and 9 (14.3%) were considered life-threatening.

Is Thrombosis in device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BIVALIRUDIN. However, 63 reports have been filed with the FAERS database.

What Other Side Effects Does BIVALIRUDIN Cause?

Drug ineffective (148) Haemorrhage (79) Off label use (73) Vascular stent thrombosis (63) Heparin-induced thrombocytopenia (61) Thrombosis (61) Coagulation time abnormal (42) Gastrointestinal haemorrhage (40) Coronary artery thrombosis (33) Cardiac arrest (28)

What Other Drugs Cause Thrombosis in device?

TREPROSTINIL (186) TICAGRELOR (154) EPOPROSTENOL (135) HEPARIN (111) CLOPIDOGREL BISULFATE (87) ASPIRIN (79) FERRIC PYROPHOSPHATE (76) AMBRISENTAN (59) BRILINTA (50) PRASUGREL (48)

Which BIVALIRUDIN Alternatives Have Lower Thrombosis in device Risk?

BIVALIRUDIN vs BLEOMYCIN BIVALIRUDIN vs BLINATUMOMAB BIVALIRUDIN vs BLONANSERIN BIVALIRUDIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BIVALIRUDIN vs BOCEPREVIR

Related Pages

BIVALIRUDIN Full Profile All Thrombosis in device Reports All Drugs Causing Thrombosis in device BIVALIRUDIN Demographics